Protalix BioTherapeutics
PLX
#8648
Rank
C$0.10 B
Marketcap
$1.49
Share price
-4.35%
Change (1 day)
-35.23%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -C$17.7 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -C$17.85 M. In 2023 the company made an earning of C$15.94 M an increase over its 2022 earnings that were of -C$16.1 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$17.7 M-211%
2023 C$15.94 M-199.05%
2022 -C$16.1 M-40.38%
2021 -C$27 M-732.31%
2020 C$4.26 M-130.53%
2019 -C$13.99 M189.85%
2018 -C$4.83 M-95.29%
2017 -C$0.11 B308.12%
2016 -C$25.11 M-32.37%
2015 -C$37.13 M10.11%
2014 -C$33.72 M-7.59%
2013 -C$36.49 M
2011 -C$42.26 M-19.39%
2010 -C$52.42 M20.87%
2009 -C$43.37 M32.26%
2008 -C$32.79 M-5.46%
2007 -C$34.68 M
2004 -C$0.23 M12.35%
2003 -C$0.2 M-11.1%
2002 -C$0.23 M-57.03%
2001 -C$0.53 M1.03%
2000 -C$0.52 M-53.22%
1999 -C$1.11 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.14 B 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.67 B-3,895.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.65 B 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.12 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel